Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073) registering the offer and sale of the Shares submitted to the Commission on [●], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 4 contracts
Samples: Underwriting Agreement (Elate Group, Inc.), Underwriting Agreement (Elate Group, Inc.), Underwriting Agreement (Elate Group, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073265178) registering the offer and sale of the Shares submitted to Securities filed with the Commission on [●]May 24, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 4 contracts
Samples: Underwriting Agreement (ParaZero Technologies Ltd.), Underwriting Agreement (ParaZero Technologies Ltd.), Underwriting Agreement (ParaZero Technologies Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073262167) registering the offer and sale of the Shares Securities submitted to the Commission on [●]January 14, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 3 contracts
Samples: Underwriting Agreement (Infinite Group Inc), Underwriting Agreement (Infinite Group Inc), Underwriting Agreement (Infinite Group Inc)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073262835) registering the offer and sale of the Shares submitted to Securities filed with the Commission on [●]February 18, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 3 contracts
Samples: Underwriting Agreement (Jeffs' Brands LTD), Underwriting Agreement (Jeffs' Brands LTD), Underwriting Agreement (Jeffs' Brands LTD)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073269419) registering the offer and sale of the Shares Securities submitted to the Commission on [●]January 26, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 3 contracts
Samples: Underwriting Agreement (Hanryu Holdings, Inc.), Underwriting Agreement (Hanryu Holdings, Inc.), Underwriting Agreement (Hanryu Holdings, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073274800) registering the offer and sale of the Shares Offered Securities submitted to the Commission on [●]September 29, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Volcon, Inc.), Underwriting Agreement (Volcon, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073[●]) registering the offer and sale of the Shares Securities submitted to the Commission on [●DATE], 2022 2021 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Maris Tech Ltd.), Underwriting Agreement (Maris Tech Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073264339) registering the offer and sale of the Shares Securities submitted to the Commission on [●]April 15, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Curative Biotechnology Inc), Underwriting Agreement (Curative Biotechnology Inc)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073265178) registering the offer and sale of the Shares submitted to the Commission on [●]May 24, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (ParaZero Technologies Ltd.), Underwriting Agreement (ParaZero Technologies Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 S-3 (File No. 333-264073269644) registering the offer and sale of the Shares Offered Securities submitted to the Commission on [●]February 8, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Volcon, Inc.), Underwriting Agreement (Volcon, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073265900) registering the offer and sale of the Shares Securities submitted to the Commission on [●]June 29, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Clearmind Medicine Inc.), Underwriting Agreement (Clearmind Medicine Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073265969) registering the offer and sale of the Shares Securities submitted to the Commission on [●]July 1, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Bruush Oral Care Inc.), Underwriting Agreement (Bruush Oral Care Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073[●]) registering the offer and sale of the Shares Securities submitted to the Commission on [●DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Wearable Devices Ltd.), Underwriting Agreement (Wearable Devices Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073276556) registering the offer and sale of the Shares Securities submitted to the Commission on [●]January 17, 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Cemtrex Inc), Underwriting Agreement (Cemtrex Inc)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073267206) registering the offer and sale of the Shares Securities submitted to the Commission on [●]August 31, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Avenue Therapeutics, Inc.), Underwriting Agreement (Avenue Therapeutics, Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073262838) registering the offer and sale of the Shares submitted to Securities filed with the Commission on [●]February 18, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Wearable Devices Ltd.), Underwriting Agreement (Wearable Devices Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073333-[●]) registering the offer and sale of the Shares Securities submitted to the Commission on [●], 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073333-[●]) registering the offer and sale of the Shares Securities submitted to the Commission on [●], 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073265400) registering the offer and sale of the Shares Securities submitted to the Commission on [●DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073269027) registering the offer and sale of the Shares submitted to the Commission on [●], 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073) registering the offer and sale of the Shares submitted to the Commission on [●]April 1, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073271377) registering the offer and sale of the Shares Securities submitted to the Commission on [●]April 21, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Samples: Underwriting Agreement (XJet Ltd.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073280253) registering the offer and sale of the Shares Securities submitted to the Commission on [●]June 17, 2022 2024 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073333-[●]) registering the offer and sale of the Shares Securities submitted to the Commission on [●DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073263715) registering the offer and sale of the Shares Securities submitted to the Commission on [●]March 18, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-3 (File No. 333-264073274841) registering the offer and sale of the Shares submitted to Securities filed with the Commission on [●]October 3, 2022 2023 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073263715) registering the offer and sale of the Shares Securities submitted to the Commission on [●DATE], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073265400) registering the offer and sale of the Shares Securities submitted to the Commission on [●]June 3, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073260670) registering the offer and sale of the Shares Securities submitted to the Commission on [●DATE], 2022 2021 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073333-[●]) registering the offer and sale of the Shares Securities submitted to the Commission on [●], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Samples: Underwriting Agreement (Bynd Cannasoft Enterprises Inc.)
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 F-1 (File No. 333-264073333-[●]) registering the offer and sale of the Shares submitted to the Commission on [●], 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Ineligible Issuer. At the time of filing of the registration statement on Form S-1 (File No. 333-264073264339) registering the offer and sale of the Shares Securities submitted to the Commission on [●]April 15, 2022 and any amendment thereto and at the date hereof, the Company was not and is not an “ineligible issuer” (as defined in Rule 405 under the Securities Act).
Appears in 1 contract
Samples: Underwriting Agreement (Curative Biotechnology Inc)